In a single key review, PecFent was demonstrated being more practical than placebo (a dummy procedure) at managing breakthrough cancer pain in eighty three adults who were being getting treated with opioids. The leading measure of performance was the modify in the severity of suffering measured with the patients rating their pain on the scale from